P.C

DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating Dentsply Sirona, Inc. on Behalf of Dentsply Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, April 26, 2022
NASDAQ, News, Telephone, Company, XRAY, GLOBE, P.C, Life insurance, Dentsply Sirona

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Dentsply Sirona, Inc. (Dentsply or the Company) (NASDAQ: XRAY) on behalf of Dentsply stockholders.

Key Points: 
  • NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Dentsply Sirona, Inc. (Dentsply or the Company) (NASDAQ: XRAY) on behalf of Dentsply stockholders.
  • Our investigation concerns whether Dentsply has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • Following this news, shares of Dentsply Sirona dropped sharply by $6.52 per share, over 13%, to close at $42.20 per share on April 19, 2022.

Sarcos Technology and Robotics Corporation Closes Acquisition of RE2, Inc.

Retrieved on: 
Monday, April 25, 2022
Software, Technology, Mobile, Wireless, Hardware, RE2, CEO, Technology, Government, Adoption, Judgement, Oshkosh Corporation, Robotics, U.S. Securities and Exchange Commission, COVID-19, Security (finance), NASDAQ, Instinct, GT, Aviation, Private Securities Litigation Reform Act, Wilson Sonsini Goodrich & Rosati, STRC, PJT Partners, Contract, Company, Solution, SEC, Forward-looking statement, NYSE, Blank Rome, Intelligence, Professional corporation, Safety, Â, Partnership, Acquisition, Risk, JLG Industries, Exercise, P.C, Risk management, Stifel, Sarcos

Sarcos Technology and Robotics Corporation (Sarcos) (NASDAQ: STRC and STRCW) today announced the successful closing of the previously announced acquisition of Pittsburgh-based robotics company RE2, Inc. , a developer of autonomous and teleoperated mobile robotic systems for use in the aviation, construction, defense, energy, and medical industries.

Key Points: 
  • Sarcos Technology and Robotics Corporation (Sarcos) (NASDAQ: STRC and STRCW) today announced the successful closing of the previously announced acquisition of Pittsburgh-based robotics company RE2, Inc. , a developer of autonomous and teleoperated mobile robotic systems for use in the aviation, construction, defense, energy, and medical industries.
  • We are delighted to officially welcome the entire RE2 team to the Sarcos family, said Kiva Allgood, President and CEO, Sarcos.
  • The combination of Sarcos and RE2 brings together two leading robotics companies working to accelerate the implementation of robotics and move the access industry forward.
  • Wilson Sonsini Goodrich & Rosati, Professional Corporation acted as legal counsel and PJT Partners acted as financial advisor to Sarcos.

PS BUSINESS PARKS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of PSB and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, April 25, 2022
NYSE, Telephone, PSB, Learning, PS Business Parks, GLOBE, Acquisition, Blackstone, Squire, P.C, Property management

On April 25, 2022, PSB announced that it had entered into an agreement to be acquired by Blackstone in a deal valued at approximately $7.6 billion.

Key Points: 
  • On April 25, 2022, PSB announced that it had entered into an agreement to be acquired by Blackstone in a deal valued at approximately $7.6 billion.
  • Pursuant to the merger agreement, PSB stockholders will receive $187.50 in cash for each share of PSB common stock owned.
  • Bragar Eagel & Squire is concerned that PSBs board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rivian, Akebia, Grab, and Celsius and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 23, 2022
R1S, News, Annual report, Grab, IPO, Chronic kidney disease, Adult, NASDAQ, MACE, Anemia, GLOBE, Patient, Offering, Mission statement, Phage r1t holin family, Program, Lists of schools in England, Defendant, Celsius, Company, Kidney, Registration statement, Register, AKBA, SUV, Therapy, Real estate, Security (finance), Audit, Pharmaceutical industry, Risk management, Online gambling, Akebia, Rivian, P.C

As a result, the price of the Companys shares was artificially and materially inflated at the time of the Offering.

Key Points: 
  • As a result, the price of the Companys shares was artificially and materially inflated at the time of the Offering.
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • For more information on the Celsius class action go to: https://bespc.com/cases/CELH
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stronghold, AbbVie, Twitter, and Li-Cycle and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 23, 2022
Janus, TWTR, Pressure, Pfizer, News, ABBV, Report, IPO, Adalimumab, Enron, RA, Regulation of tobacco by the U.S. Food and Drug Administration, NASDAQ, U.S. Securities and Exchange Commission, Food, Musk, AbbVie, GLOBE, Ownership, Growth, Miner, Review, Lists of schools in England, Defendant, Rheumatoid arthritis, Company, Complaint, Mining, Registration statement, SEC, NYSE, Kleffman v. Vonage Holdings Corp., Register, Abuse, Safety, SDIG, FDA, Industry, JAK, Risk, Minerva, Disclosure, Cancer, Pharmaceutical industry, Renewable energy, Cryptocurrency, Audit, Medical device, Twitter, Tofacitinib, Upadacitinib, Forbes, P.C

In October 2021, the Company completed its IPO, selling 7,690,400 shares of Class A common stock at $19.00 per share.

Key Points: 
  • In October 2021, the Company completed its IPO, selling 7,690,400 shares of Class A common stock at $19.00 per share.
  • On March 29, 2022, after the market closed, Stronghold announced its fourth quarter and full year 2021 financial results.
  • For more information on the Stronghold class action go to: https://bespc.com/cases/SDIG
    AbbVie is one of the world's largest pharmaceutical companies.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FAT, Cano, Vertiv, and Homology and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 23, 2022
News, CEO, Medicare, Letter, Awareness, Weeping Angel, Ponderosa and Bonanza Steakhouses, Regulation of tobacco by the U.S. Food and Drug Administration, NASDAQ, PKU, Liver function tests, Food, CANO, Program, GLOBE, Patient, COO, VRT, FAT, Lists of diseases, Lists of schools in England, Defendant, Social media, Company, Complaint, Phenix, NYSE, Phenylketonuria, Sailor, ASC, Face, Risk, Alfred Wegener Institute for Polar and Marine Research, Fatburger, P.C, Pharmaceutical industry, Risk management, Audit, Vertiv, Q4, Homology, Andrew Wiederhorn, Time (disambiguation)

The class action focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Key Points: 
  • The class action focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • FAT Brands is the subject of a report published by the Los Angeles Times on February 19, 2022.
  • On this news, FAT Brands' stock fell $2.42, or 22.9%, to close at $8.14 per share on February 22, 2022, thereby injuring investors.
  • For more information on the Homology class action go to: https://bespc.com/cases/FIXX
    About Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Volta, Embark, Lucid, and Lilium and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 23, 2022
News, CEO, Board, Jet, Technology, Lilium, NASDAQ, Combination, NV, Lilium Jet, EVTOL, GLOBE, Cell, Bear's Cave (Erpfingen), Mission statement, Lists of schools in England, SPAC, Defendant, Company, Iceberg, NYSE, General Motors, Research, Certification, Industry, Bears' Cave, Acquisition, Business architecture, Financial services, Pharmaceutical industry, Risk management, Audit, Renewable energy, Embark, Lucid, P.C

Then, on March 21, 2022, Volta announced that it would reschedule its fourth quarter and full year 2021 financial results.

Key Points: 
  • Then, on March 21, 2022, Volta announced that it would reschedule its fourth quarter and full year 2021 financial results.
  • For more information on the Volta class action go to: https://bespc.com/cases/VLTA
    Embark develops self-driving software solutions for the trucking industry in the U.S.
  • For more information on the Lilium class action go to: https://bespc.com/cases/LILM
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Affirm, Cabaletta, Ericsson, and C3.ai and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 23, 2022
News, Adoption, IPO, Ericsson, International Consortium of Investigative Journalists, NASDAQ, American depositary receipt, Compliance, Cabaletta, GLOBE, CABA, Clinical trial, Lists of schools in England, Defendant, Technology, Shareholder, Company, ICIJ, American, Complaint, NYSE, Islam, Partnership, ADS, Baker Hughes, ISIS, Risk management, Renewable energy, Audit, Pharmaceutical industry, Tweet, P.C

Through its platform, the Company offers buy now, pay later or BNPL services to consumers.

Key Points: 
  • Through its platform, the Company offers buy now, pay later or BNPL services to consumers.
  • The Tweet was materially misleading, in that it omitted to disclose the full details of Affirms second quarter financial results.
  • Additionally, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • For more information on the C3.ai class action go to: https://bespc.com/cases/AI
    About Bragar Eagel & Squire, P.C.

ENSERVCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Enservco Corp. on Behalf of Enservco Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 23, 2022
Relevant, News, Telephone, U.S. Securities and Exchange Commission, ENSV, GLOBE, Mission statement, Company, NYSE, P.C

NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Enservco Corp. (Enservco or the Company) (NYSE: ENSV) on behalf of Enservco stockholders.

Key Points: 
  • NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Enservco Corp. (Enservco or the Company) (NYSE: ENSV) on behalf of Enservco stockholders.
  • Our investigation concerns whether Enservco has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • On this news, Enservcos stock price fell sharply during intraday trading on April 19, 2022.

CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Cassava Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 23, 2022
NASDAQ, News, Experiment, Telephone, The New York Times, PLOS One, GLOBE, P.C, Cassava

NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cassava Sciences, Inc. (Cassava or the Company) (NASDAQ: SAVA) on behalf of Cassava stockholders.

Key Points: 
  • NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cassava Sciences, Inc. (Cassava or the Company) (NASDAQ: SAVA) on behalf of Cassava stockholders.
  • Our investigation concerns whether Cassava has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On April 18, 2022, The New York Times published an article entitled Scientists Question Data Behind an Experimental Alzheimers Drug.
  • The article addressed Cassavas experimental Alzheimers drug, simufilam, and reported that one of Cassavas advisers, Dr. H.Y.